David B. Arciniegas, MD serves as the Cooper Neuropsychiatry Scholar and Professor of Neurology and Psychiatry at the University of Colorado Anschutz Medical Campus in Aurora, CO; as Clinical Professor of Psychiatry and Behavioral Sciences at the University of New Mexico School of Medicine in Albuquerque, NM; and as Clinical Professor of Psychiatry and Behavioral Sciences at the Baylor College of Medicine in Houston, TX. As a subspecialist in Behavioral Neurology & Neuropsychiatry, his clinical, research, educational activities over the last three decades have focused principally on the assessment and treatment of the cognitive and non-cognitive neuropsychiatric sequelae of traumatic brain injury (TBI). His research employs multimodal clinical assessments and their integration into single- and multi-center clinical trials focused on the diagnosis, pharmacotherapy, and psychosocial treatment of the neuropsychiatric consequences of these conditions. Since 1996, his work has been supported by more than 40 extramurally supported research projects, including more than 20 federally funded research grants and four multicenter randomized controlled trials of pharmacotherapies for neuropsychiatric sequelae of TBI. He has authored more than 160 articles in peer-reviewed journals, authored or edited eight medical textbooks, 42 book chapters, and more than 50 other works communicating to scientific colleagues and the general public. He has delivered more than 350 scientific to professional and lay audiences in the United States and abroad, including a dozen named lectureships and keynote addresses. His research, clinical, education, professional service, and administrative endeavors have been recognized by multiple institutional, national, and international awards, including the Brain Injury Association of Colorado’s Outstanding Contribution Award; the Mitch Rosenthal Award for Scientific and Clinical Achievement in Brain Injury Rehabilitation from Virginia Commonwealth University and Brain Injury Services, Inc.; the Innovative Clinical Treatment Award from the North American Brain Injury Society; the ACLP Foundation Research Professor Award from the Academy of Consultation-Liaison Psychiatry; and, following on his leadership of International Brain Injury Association as its Chair and CEO, the distinction of shared eponymous honoree of the association’s Zasler-Arciniegas Lecture. He presently serves as Editor of the Journal of Neuropsychiatry and Clinical Neurosciences as Immediate Past President of the American Neuropsychiatric Association.